Potential viral pathogenic mechanism for now variant inflammatory bowel disease

Coombe Women & Infants University Hospital, Dublin, Leinster, Ireland
Molecular Pathology 05/2002; 55(2):84-90.
Source: PubMed


A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disorder. This study investigates the presence of persistent measles virus in the intestinal tissue of these patients (new variant inflammatory bowel disease) and a series of controls by molecular analysis.
Formalin fixed, paraffin wax embedded and fresh frozen biopsies from the terminal ileum were examined from affected children and histological normal controls. The measles virus Fusion (F) and Haemagglutinin (H) genes were detected by TaqMan reverse transcription polymerase chain reaction (RT-PCR) and the Nucleocapsid (N) gene by RT in situ PCR. Localisation of the mRNA signal was performed using a specific follicular dendritic cell antibody.
Seventy five of 91 patients with a histologically confirmed diagnosis of ileal lymphonodular hyperplasia and enterocolitis were positive for measles virus in their intestinal tissue compared with five of 70 control patients. Measles virus was identified within the follicular dendritic cells and some lymphocytes in foci of reactive follicular hyperplasia. The copy number of measles virus ranged from one to 300,00 copies/ng total RNA.
The data confirm an association between the presence of measles virus and gut pathology in children with developmental disorder.

Download full-text


Available from: Orla Sheils
  • Source
    • "In other words authors keep shuffling with assumptions as if referring to them as well known facts was enough to provide high-quality data. A good awareness rising example is a report of " catalogue of mistakes , inaccuracies and inappropriate analysis methods as well as contamination and poor assay performance " carried out by Bustin (2008) acting as an expert witness in court for specific case where he was undermining conclusion of a link between authism and entheropathy as previously stated by Uhlmann et al. (2002). It is frequently raised that a consensus on how to perform and evaluate qPCR experiment does not exist which implicates a kind of conservatism in citing references. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper aims to discuss various aspects of the use of reference genes in qPCR technique used in the thousands of present studies. Most frequently, these are housekeeping genes and they must meet several criteria so that they can lay claim to the name. Lots of papers report that in different conditions, for different organisms and even tissues the basic assumption-the constant level of the expression is not maintained for many genes that seem to be perfect candidates. Moreover, their transcription can not be affected by experimental factors. Sounds simple and clear but a great number of designed protocols and lack of consistency among them brings confusion on how to perform experiment properly. Since during selection of the most stable normalizing gene we can not use any reference gene, different ways and algorithms for their selection were developed. Such methods, including examples of best normalizing genes in some specific cases and possible mistakes are presented based on available sources. Numerous examples of reference genes applications, which are usually in too few numbers in relevant articles not allowing to make a solid fundament for a reader, will be shown along with instructive compilations to make an evidence for presented statements and an arrangement of future qPCR experiments. To include all the pitfalls and problems associated with the normalization methods there is no way not to begin from sample preparation and its storage going through candidate gene selection, primer design and statistical analysis. This is important because numerous short reviews available cover the topic only in lesser extent at the same time giving the reader false conviction of complete topic recognition.
    Full-text · Article · Sep 2013 · Journal of applied genetics
  • Source
    • "This contrasts with the sharp increase in media coverage starting in the spring of 2001, with 20 articles appearing in a single quarter. In terms of content, all four instances of claims of potential side-effects were reported; indeed, the two spikes in media coverage in the spring of 2001 and 2002 were sparked by the two publications appearing at those times (Wakefield and Montgomery, 2001 and Uhlmann et al, 2002). The majority of the aforementioned main studies finding no link between the MMR and autism were also reported. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The measles, mumps and rubella (MMR) controversy provides an interesting case where, for a short period of time, research publicized in the media, suggested a potential risk of serious side-effects associated with the vaccine, where there was also a sharp behavioral response from the public, and where the initial information was subsequently overturned. We consider the controversy from the perspective of health inequalities and the assimilation of information, focusing on whether and how vaccine uptake behavior in the wake of the controversy differed among groups of parents by education and income. Using panel data on the variation in the uptake of the MMR, and other childhood immunizations, across local Health Authority areas we find that the uptake rate of the MMR declined faster in areas where a larger fraction of parents had stayed in education past the age of 18 than in areas with less educated parents. We also find that the same areas reduced their relative uptake of other uncontroversial childhood immunizations, suggesting a "spillover" effect. Using a supplementary data source we find evidence of a corresponding positive income effect, indicating that wealthier parents avoided the MMR dilemma by purchasing single vaccines.
    Full-text · Article · Mar 2011 · Journal of Health Economics
  • Source
    • "Review of the pathophysiology found in some autistic individuals in conjunction with the mechanisms of action of HBOT lead to the speculation that HBOT might produce clinical improvements in autistic individuals [11]. Several studies indicate that some autistic individuals manifest cerebral hypoperfusion [33-35], neuroinflammation [36-38], and gastrointestinal inflammation [39,40]. HBOT might ameliorate some of these problems by improving cerebral hypoperfusion [17,21,31,41], and by decreasing neuroinflammation and gastrointestinal inflammation [42-47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently, hyperbaric oxygen therapy (HBOT) has increased in popularity as a treatment for autism. Numerous studies document oxidative stress and inflammation in individuals with autism; both of these conditions have demonstrated improvement with HBOT, along with enhancement of neurological function and cognitive performance. In this study, children with autism were treated with HBOT at atmospheric pressures and oxygen concentrations in current use for this condition. Changes in markers of oxidative stress and inflammation were measured. The children were evaluated to determine clinical effects and safety. Eighteen children with autism, ages 3-16 years, underwent 40 hyperbaric sessions of 45 minutes duration each at either 1.5 atmospheres (atm) and 100% oxygen, or at 1.3 atm and 24% oxygen. Measurements of C-reactive protein (CRP) and markers of oxidative stress, including plasma oxidized glutathione (GSSG), were assessed by fasting blood draws collected before and after the 40 treatments. Changes in clinical symptoms, as rated by parents, were also assessed. The children were closely monitored for potential adverse effects. At the endpoint of 40 hyperbaric sessions, neither group demonstrated statistically significant changes in mean plasma GSSG levels, indicating intracellular oxidative stress appears unaffected by either regimen. A trend towards improvement in mean CRP was present in both groups; the largest improvements were observed in children with initially higher elevations in CRP. When all 18 children were pooled, a significant improvement in CRP was found (p = 0.021). Pre- and post-parental observations indicated statistically significant improvements in both groups, including motivation, speech, and cognitive awareness (p < 0.05). No major adverse events were observed. In this prospective pilot study of children with autism, HBOT at a maximum pressure of 1.5 atm with up to 100% oxygen was safe and well tolerated. HBOT did not appreciably worsen oxidative stress and significantly decreased inflammation as measured by CRP levels. Parental observations support anecdotal accounts of improvement in several domains of autism. However, since this was an open-label study, definitive statements regarding the efficacy of HBOT for the treatment of individuals with autism must await results from double-blind, controlled trials. NCT00324909.
    Full-text · Article · Nov 2007 · BMC Pediatrics
Show more